Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 320,165 shares of BLFS, which is worth approximately $8.02 Million. The most recent transaction as insider was on Oct 20, 2021, when has been sold 10,000 shares (Common Stock) at a price of $41.97 per share, resulting in proceeds of $419,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K

21.68% 3M change

0.01% 12M change

Total Value Held $8.02 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 20 2021	SELL Open market or private sale	$419,700 $41.97 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Oct 20 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Oct 18 2021	SELL Open market or private sale	$413,400 $41.34 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Oct 18 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Oct 14 2021	SELL Open market or private sale	$50,882 $39.97 p/Share	1,273 Reduced 0.61%	207,198 Common Stock
Sep 28 2021	SELL Open market or private sale	$31,003 $43.12 p/Share	719 Reduced 0.34%	208,471 Common Stock
Sep 22 2021	SELL Open market or private sale	$469,900 $46.99 p/Share	10,000 Reduced 4.56%	209,190 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,190 Common Stock
Sep 20 2021	SELL Open market or private sale	$468,900 $46.89 p/Share	10,000 Reduced 4.56%	209,190 Common Stock
Sep 20 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,190 Common Stock
Aug 27 2021	SELL Open market or private sale	$22,847 $57.26 p/Share	399 Reduced 0.19%	209,190 Common Stock
Aug 25 2021	SELL Open market or private sale	$531,200 $53.12 p/Share	10,000 Reduced 4.55%	209,589 Common Stock
Aug 25 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,589 Common Stock
Aug 23 2021	SELL Open market or private sale	$465,400 $46.54 p/Share	10,000 Reduced 4.55%	209,589 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,589 Common Stock
Jul 21 2021	SELL Open market or private sale	$403,831 $45.61 p/Share	8,854 Reduced 4.05%	209,589 Common Stock
Jul 21 2021	BUY Exercise of conversion of derivative security	$14,521 $1.64 p/Share	8,854 Added 3.9%	218,443 Common Stock
Jul 19 2021	SELL Open market or private sale	$438,500 $43.85 p/Share	10,000 Reduced 4.55%	209,589 Common Stock
Jul 19 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,589 Common Stock
Jun 29 2021	SELL Open market or private sale	$31,281 $43.75 p/Share	715 Reduced 0.34%	209,589 Common Stock
Jun 16 2021	SELL Open market or private sale	$392,700 $39.27 p/Share	10,000 Reduced 4.54%	210,304 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,304 Common Stock
Jun 14 2021	SELL Open market or private sale	$389,000 $38.9 p/Share	10,000 Reduced 4.54%	210,304 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,304 Common Stock
May 28 2021	SELL Open market or private sale	$12,701 $33.87 p/Share	375 Reduced 0.18%	210,304 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account